Journal: Diabetes Spectrum : A Publication of the American Diabetes Association

Article Title: Management of Adults With Diabetes and Cognitive Problems

doi: 10.2337/ds16-0035

Figure Lengend Snippet: Assistive Devices for People With Diabetes and Cognitive Impairment and Their Caregivers

Article Snippet: CGM devices , 1. CGM devices for personal wear (e.g., Dexcom G5, Medtronic Enlite, or Medtronic Guardian): alert patients or caregivers to fluctuating blood glucose levels and blood glucose levels that are above or below preset parameters. The share feature of the Dexcom G5 might be particularly useful in patients with cognitive impairment. 2. mySentry Remote Glucose Monitor: a device that displays a patient’s blood glucose levels but can be set up in a caretaker’s room. Customizable alarms can be set to alert the caregiver to dangerous glucose levels. 3. CGM devices for professional use (e.g., Dexcom G4 Platinum professional or Medtronic iPro2 Professional CGM: used to track a patient’s glucose levels for a designated number of days; data downloading allows the medical provider to see glucose trends, glycemic excursions, and problematic glucose patterns and direct changes in therapy to address them..

Techniques: Medications, Stripping Membranes

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Daily and Annual Costs of Diabetes Treatment Supplies a

Article Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a Table A15: Intervention Brands (Approved in Canada) Diabetes Treatment Supplies Insulin Treatment CGM Insulin Pump Total Cost SAP Dexcom G4 Platinum + Animas Vibe $1,066 $734 $5,720 $4,290 $11,811 SAP Dexcom G5 Mobile + Animas Vibe or MiniMed VEO $533 $734 $5,976 $4,290 $11,534 SAP with LGS MiniMed Veo with LGS $1,066 $734 $3,120 $4,290 $9,211 CGM + MDI Dexcom G4 Platinum $2,329 $1,348 $6,420 — $10,097 CGM + MDI Dexcom G5 Mobile $1,263 $1,348 $5,976 — $8,587 SMBG + insulin pump Animas Vibe and MiniMed Veo $1,599 $734 — $4,484 $6,817 SMBG + MDI $2,329 $1,348 — — $3,677 Open in a separate window Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend; MDI, multiple daily injections; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose. a All costs are presented in 2017 Canadian dollars.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a

Article Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a Table A15: Intervention Brands (Approved in Canada) Diabetes Treatment Supplies Insulin Treatment CGM Insulin Pump Total Cost SAP Dexcom G4 Platinum + Animas Vibe $1,066 $734 $5,720 $4,290 $11,811 SAP Dexcom G5 Mobile + Animas Vibe or MiniMed VEO $533 $734 $5,976 $4,290 $11,534 SAP with LGS MiniMed Veo with LGS $1,066 $734 $3,120 $4,290 $9,211 CGM + MDI Dexcom G4 Platinum $2,329 $1,348 $6,420 — $10,097 CGM + MDI Dexcom G5 Mobile $1,263 $1,348 $5,976 — $8,587 SMBG + insulin pump Animas Vibe and MiniMed Veo $1,599 $734 — $4,484 $6,817 SMBG + MDI $2,329 $1,348 — — $3,677 Open in a separate window Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend; MDI, multiple daily injections; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose. a All costs are presented in 2017 Canadian dollars.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Costs of Different Diabetes Treatment Technologies a

Article Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a Table A15: Intervention Brands (Approved in Canada) Diabetes Treatment Supplies Insulin Treatment CGM Insulin Pump Total Cost SAP Dexcom G4 Platinum + Animas Vibe $1,066 $734 $5,720 $4,290 $11,811 SAP Dexcom G5 Mobile + Animas Vibe or MiniMed VEO $533 $734 $5,976 $4,290 $11,534 SAP with LGS MiniMed Veo with LGS $1,066 $734 $3,120 $4,290 $9,211 CGM + MDI Dexcom G4 Platinum $2,329 $1,348 $6,420 — $10,097 CGM + MDI Dexcom G5 Mobile $1,263 $1,348 $5,976 — $8,587 SMBG + insulin pump Animas Vibe and MiniMed Veo $1,599 $734 — $4,484 $6,817 SMBG + MDI $2,329 $1,348 — — $3,677 Open in a separate window Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend; MDI, multiple daily injections; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose. a All costs are presented in 2017 Canadian dollars.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Per-Patient Costs of Continuous Glucose Monitoring When Insulin Pump, Insulin, and Supplies Are Publicly Funded

Article Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a Table A15: Intervention Brands (Approved in Canada) Diabetes Treatment Supplies Insulin Treatment CGM Insulin Pump Total Cost SAP Dexcom G4 Platinum + Animas Vibe $1,066 $734 $5,720 $4,290 $11,811 SAP Dexcom G5 Mobile + Animas Vibe or MiniMed VEO $533 $734 $5,976 $4,290 $11,534 SAP with LGS MiniMed Veo with LGS $1,066 $734 $3,120 $4,290 $9,211 CGM + MDI Dexcom G4 Platinum $2,329 $1,348 $6,420 — $10,097 CGM + MDI Dexcom G5 Mobile $1,263 $1,348 $5,976 — $8,587 SMBG + insulin pump Animas Vibe and MiniMed Veo $1,599 $734 — $4,484 $6,817 SMBG + MDI $2,329 $1,348 — — $3,677 Open in a separate window Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend; MDI, multiple daily injections; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose. a All costs are presented in 2017 Canadian dollars.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Per-Patient Costs (All Direct Medical Costs) of Continuous Glucose Monitoring in Ontario

Article Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a Table A15: Intervention Brands (Approved in Canada) Diabetes Treatment Supplies Insulin Treatment CGM Insulin Pump Total Cost SAP Dexcom G4 Platinum + Animas Vibe $1,066 $734 $5,720 $4,290 $11,811 SAP Dexcom G5 Mobile + Animas Vibe or MiniMed VEO $533 $734 $5,976 $4,290 $11,534 SAP with LGS MiniMed Veo with LGS $1,066 $734 $3,120 $4,290 $9,211 CGM + MDI Dexcom G4 Platinum $2,329 $1,348 $6,420 — $10,097 CGM + MDI Dexcom G5 Mobile $1,263 $1,348 $5,976 — $8,587 SMBG + insulin pump Animas Vibe and MiniMed Veo $1,599 $734 — $4,484 $6,817 SMBG + MDI $2,329 $1,348 — — $3,677 Open in a separate window Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend; MDI, multiple daily injections; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose. a All costs are presented in 2017 Canadian dollars.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Per-Patient Costs of Continuous Glucose Monitoring when Insulin Pump, Insulin, and 75% of Sensor Costs Are Publicly Funded

Article Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a Table A15: Intervention Brands (Approved in Canada) Diabetes Treatment Supplies Insulin Treatment CGM Insulin Pump Total Cost SAP Dexcom G4 Platinum + Animas Vibe $1,066 $734 $5,720 $4,290 $11,811 SAP Dexcom G5 Mobile + Animas Vibe or MiniMed VEO $533 $734 $5,976 $4,290 $11,534 SAP with LGS MiniMed Veo with LGS $1,066 $734 $3,120 $4,290 $9,211 CGM + MDI Dexcom G4 Platinum $2,329 $1,348 $6,420 — $10,097 CGM + MDI Dexcom G5 Mobile $1,263 $1,348 $5,976 — $8,587 SMBG + insulin pump Animas Vibe and MiniMed Veo $1,599 $734 — $4,484 $6,817 SMBG + MDI $2,329 $1,348 — — $3,677 Open in a separate window Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend; MDI, multiple daily injections; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose. a All costs are presented in 2017 Canadian dollars.

Techniques:

Journal: European Endocrinology

Article Title: Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach

doi: 10.17925/EE.2018.14.1.24

Figure Lengend Snippet: Summary of characteristics and features of the Abbott Libre, Dexcom G5 and Medtronic Enlite systems as indicated for use outside the US

Article Snippet: This expanded interoperability allows users to analyse their Dexcom G5 glucose data in conjunction with a variety of devices and health support apps and programmes.

Techniques:

Journal: European Endocrinology

Article Title: Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach

doi: 10.17925/EE.2018.14.1.24

Figure Lengend Snippet: Summary of characteristics and features of the Abbott Libre, Dexcom G5 and Medtronic Enlite systems as indicated for use outside the US

Article Snippet: This expanded interoperability allows users to analyse their Dexcom G5 glucose data in conjunction with a variety of devices and health support apps and programmes.

Techniques:

Journal: Journal of Diabetes Science and Technology

Article Title: Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation

doi: 10.1177/1932296818813581

Figure Lengend Snippet: Available Professional and Personal CGM Systems (FDA Approved).

Article Snippet: 48 - 50 table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Medtronic MiniMed Enlite 2 (530G) Medtronic MiniMed Guardian 3 (670G) Enlite 2 (630G) Guardian Connect Dexcom G4 Platinum G5, t:slim X2 G6, t:slim X2-Basal IQ FreeStyle Libre Senseonics Eversense N/A Glucose is rising at a rate of ⩾3 mg/dL per minute N/A N/A N/A Glucose is rising at a rate of 2 mg/dL or more per minute Glucose is rising at a rate of ⩾2 but <3 mg/dL per minute Glucose is rapidly rising >3 mg/dL per minute N/A N/A Glucose is rising at a rate of 1 to 2 mg/dL per minute Glucose is rising at a rate of ⩾1 but <2 mg/dL per minute Glucose is rising 2-3 mg/dL per minute Glucose is rising quickly (>2 mg/dL per minute) Very rapidly rising glucose levels, rising at a rate more than 2 mg/dL per minute N/A N/A Glucose is slowly rising 1-2 mg/dL per minute Glucose is rising (1-2 mg/dL per minute) Moderately rising glucose level, rising at a rate between 1 mg/dL and 2 mg/dL per minute N/A N/A Steady; glucose is not increasing/decreasing >1 mg/dL per minute Glucose is changing slowly (<1 mg/dL per minute) Gradually rising or falling glucose levels, falling or rising at a rate between 0 and 1 mg/dL per minute N/A N/A Glucose is slowly falling 1-2 mg/dL per minute Glucose is falling (1-2 mg/dL per minute) Moderately falling glucose levels, falling at a rate between 1 mg/dL and 2 mg/dL per minute Glucose is falling at a rate of 1 to 2 mg/dL per minute Glucose is falling at a rate of ⩾1 but <2 mg/dL per minute Glucose is falling 2-3 mg/dL per minute Glucose is falling quickly (>2 mg/dL per minute) Very rapidly falling glucose levels, falling at a rate more than 2 mg/dL per minute Glucose is falling at a rate of 2 mg/dL or more per minute Glucose is falling at a rate of ⩾2 but <3 mg/dL per minute Glucose is rapidly falling >3 mg/dL per minute N/A N/A N/A Glucose is falling at a rate of ⩾3 mg/dL per minute N/A N/A N/A Open in a separate window Rate of Change Trend Arrows in FDA-Approved CGM Systems and Integrated Insulin Pump Systems.

Techniques: Software

Journal: Journal of Diabetes Science and Technology

Article Title: Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation

doi: 10.1177/1932296818813581

Figure Lengend Snippet: Rate of Change Trend Arrows in FDA-Approved CGM Systems and Integrated Insulin Pump Systems.

Article Snippet: 48 - 50 table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Medtronic MiniMed Enlite 2 (530G) Medtronic MiniMed Guardian 3 (670G) Enlite 2 (630G) Guardian Connect Dexcom G4 Platinum G5, t:slim X2 G6, t:slim X2-Basal IQ FreeStyle Libre Senseonics Eversense N/A Glucose is rising at a rate of ⩾3 mg/dL per minute N/A N/A N/A Glucose is rising at a rate of 2 mg/dL or more per minute Glucose is rising at a rate of ⩾2 but <3 mg/dL per minute Glucose is rapidly rising >3 mg/dL per minute N/A N/A Glucose is rising at a rate of 1 to 2 mg/dL per minute Glucose is rising at a rate of ⩾1 but <2 mg/dL per minute Glucose is rising 2-3 mg/dL per minute Glucose is rising quickly (>2 mg/dL per minute) Very rapidly rising glucose levels, rising at a rate more than 2 mg/dL per minute N/A N/A Glucose is slowly rising 1-2 mg/dL per minute Glucose is rising (1-2 mg/dL per minute) Moderately rising glucose level, rising at a rate between 1 mg/dL and 2 mg/dL per minute N/A N/A Steady; glucose is not increasing/decreasing >1 mg/dL per minute Glucose is changing slowly (<1 mg/dL per minute) Gradually rising or falling glucose levels, falling or rising at a rate between 0 and 1 mg/dL per minute N/A N/A Glucose is slowly falling 1-2 mg/dL per minute Glucose is falling (1-2 mg/dL per minute) Moderately falling glucose levels, falling at a rate between 1 mg/dL and 2 mg/dL per minute Glucose is falling at a rate of 1 to 2 mg/dL per minute Glucose is falling at a rate of ⩾1 but <2 mg/dL per minute Glucose is falling 2-3 mg/dL per minute Glucose is falling quickly (>2 mg/dL per minute) Very rapidly falling glucose levels, falling at a rate more than 2 mg/dL per minute Glucose is falling at a rate of 2 mg/dL or more per minute Glucose is falling at a rate of ⩾2 but <3 mg/dL per minute Glucose is rapidly falling >3 mg/dL per minute N/A N/A N/A Glucose is falling at a rate of ⩾3 mg/dL per minute N/A N/A N/A Open in a separate window Rate of Change Trend Arrows in FDA-Approved CGM Systems and Integrated Insulin Pump Systems.

Techniques: